Kaplan-Meier survival and Cox regression analyses revealed that a high CD133 expression in the nucleus, as well as in the cytoplasm also predicted the poor prognosis of NSCLC (15). The gene discussed is PROM1; the disease is non-small cell lung carcinoma.